Apollo Hospitals Enterprise Ltd., incorporated in the year 1979, is a Large Cap company (having a market cap of Rs 62776.38 Crore) operating in Hospitals & Allied Services sector.
Apollo Hospitals Enterprise Ltd. key Products/Revenue Segments include HealthCare Services and Other Operating Revenue for the year ending 31-Mar-2022.
For the quarter ended 30-06-2022, the company reported a Consolidated Total Income of Rs 3811.66 Crore, up 6.56 % from last quarter Total Income of Rs 3577.15 Crore and up .71 % from last year same quarter Total Income of Rs 3784.85 Crore . Company reported net profit after tax of Rs 335.80 Crore in latest quarter.
Apollo Hospitals remains our top pick in healthcare space given 1) the company is best play amongst Omni-channels with ~7864 operational beds; 2) Scale up B2C diagnostic segment with target of Rs10bn revenues in next 3 years vs Rs4bn in FY22; 3) Multiple growth levers in place along with 1000-2000 beds addition through brownfield expansion; 4) Digital health space foray to help APHS cross sell its services to a larger population; and 5) Estimated 18% revenue CAGR, 20% EBITDA CAGR over FY22-24E and 60bps margin expansion over FY22-24E.
Promoters held 58.66 per cent stake in the company as of 30-Sep-2022, while FIIs owned 48.48 per cent, DIIs 30.44 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.